FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagehl7.fhir.uv.xver-r3.r4b
Resource TypeValueSet
IdValueSet-R3-v3-EntityNamePartQualifierR2-for-R4B.json
FHIR VersionR4B
Sourcehttp://hl7.org/fhir/uv/xver-r3.r4b/0.1.0/ValueSet-R3-v3-EntityNamePartQualifierR2-for-R4B.html
URLhttp://hl7.org/fhir/uv/xver/ValueSet/R3-v3-EntityNamePartQualifierR2-for-R4B
Version0.1.0
Statusactive
Date2026-03-17T21:02:03.8104715+00:00
NameR3V3EntityNamePartQualifierR2ForR4B
TitleCross-version ValueSet STU3.v3 Code System EntityNamePartQualifierR2 for use in FHIR R4B
Realmuv
Authorityhl7
DescriptionThis cross-version ValueSet represents content from `http://hl7.org/fhir/ValueSet/v3-EntityNamePartQualifierR2|2016-11-11` for use in FHIR R4B.
PurposeThis value set is part of the cross-version definitions generated to enable use of the value set `http://hl7.org/fhir/ValueSet/v3-EntityNamePartQualifierR2|2016-11-11` as defined in FHIR STU3 in FHIR R4B. The source value set is bound to the following FHIR STU3 elements: * Across FHIR versions, the value set has been mapped as: * `http://hl7.org/fhir/ValueSet/v3-EntityNamePartQualifierR2|2016-11-11` * `http://terminology.hl7.org/ValueSet/v3-EntityNamePartQualifierR2|2018-08-12` Note that all concepts are included in this cross-version definition because no concepts have compatible representations Following are the generation technical comments: All concepts in the comparison are listed as identical. The source and target value sets have the same number of active concepts (25). FHIR ValueSet `http://hl7.org/fhir/ValueSet/v3-EntityNamePartQualifierR2|2016-11-11`, defined in FHIR STU3 does not have any mapping to FHIR R4B

Resources that use this resource

No resources found

Resources that this resource uses

CodeSystem
hl7.fhir.uv.xver-r2.r4b#0.1.0EntityNamePartQualifierR2v3-EntityNamePartQualifierR2

Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: ValueSet R3-v3-EntityNamePartQualifierR2-for-R4B

This value set expansion contains 27 concepts.

SystemVersionCodeDisplayDefinition
http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  ACacademic

Description:Indicates that a title like "Dr.", "M.D." or "Ph.D." is an academic title.

http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  ADacquired

Description:A name part a person acquired. The name part may be acquired by adoption, or the person may have chosen to use the name part for some other reason.

                       Note: this differs from an Other/Psuedonym/Alias in that an acquired name part is acquired on a formal basis rather than an informal one (e.g. registered as part of the official name).
http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  BRbirth

Description:A name that a person was given at birth or established as a consequence of adoption.

                       Note: This is not used for temporary names assigned at birth such as "Baby of Smith" a" which is just a name with a use code of "TEMP".
http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  CLcallme

Description:Used to indicate which of the various name parts is used when interacting with the person.

http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  CONcontainer name

Description: This refers to the container if present in the medicinal product name.

                    EXAMPLES: 

                    
                       
                          For Optaflu suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell culture) (2007/2008 season): pre-filled syringe
http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  DEVdevice name

Description: This refers to the qualifiers in the name for devices and is at the moment mainly applicable to insulins and inhalation products.

                    EXAMPLES: 

                    
                       
                          For the medicinal product Actrapid FlexPen 100 IU/ml Solution for injection Subcutaneous use: FlexPen.
http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  FLAVFlavorName

Description: This refers to a flavor of the medicinal product if present in the medicinal product name.

                       Examples:
                    

                    
                       For 'CoughCure Linctus Orange Flavor', the flavor part is "Orange"
                       For 'Wonderdrug Syrup Cherry Flavor', the flavor part is "Cherry"
http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  FORMULFormulationPartName

Description: This refers to the formulation of the medicinal product if present in the medicinal product name.

                       Examples:
                    

                    
                       For 'SpecialMed Sugar Free Cough Syrup', the formulation name part is "Sugar Free"
                       For 'QuickCure Gluten-free Bulk Fibre', the formulation name part is "gluten-free"
http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  FRMform name

Description: This refers to the pharmaceutical form/ if present in the medicinal product name.

                    EXAMPLES: 

                    
                       
                          For Agenerase 50 mg soft capsules: Soft Capsules

                       
                       
                          For Ludiomil 25mg-Filmtabletten: Filmtabletten

                       
                       
                          For Optaflu suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell culture) (2007/2008 season): suspension for injection
http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  HONhonorific

Description:A honorific such as "The Right Honourable" or "Weledelgeleerde Heer".

http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  INinitial

Description:Indicates that a name part is just an initial. Initials do not imply a trailing period since this would not work with non-Latin scripts. In some languages, initials may consist of more than one letter, e.g., "Ph" could stand for "Philippe" or "Th" For "Thomas".

http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  INVinvented name

Description: This refers to the product name without the trademark or the name of the marketing authorization holder or any other descriptor reflected in the product name and, if appropriate, whether it is intended e.g. for babies, children or adults.

                    EXAMPLES: 

                    
                       
                          Agenerase

                       
                       
                          Optaflu

                       
                       
                          Ludiomil
http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  LSlegal status

Description:For organizations a suffix indicating the legal status, e.g., "Inc.", "Co.", "AG", "GmbH", "B.V." "S.A.", "Ltd." etc.

http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  MIDmiddle name

Description:Indicates that the name part is a middle name.

                       Usage Notes: In general, the english "middle name" concept is all of the given names after the first. This qualifier may be used to explicitly indicate which given names are considered to be middle names. The middle name qualifier may also be used with family names. This is a Scandinavian use case, matching the concept of "mellomnavn","mellannamn". Note that there are specific rules that indicate what names may be taken as a mellannamn in different Scandinavian countries.
http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  NBnobility

Description:A nobility title such as Sir, Count, Grafin.

http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  PFXprefix

Description:A prefix has a strong association to the immediately following name part. A prefix has no implicit trailing white space (it has implicit leading white space though).

http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  POPULTargetPopulationName

Description: This refers to the target population for the medicinal product if present in the medicinal product name

                       Examples:
                    

                    
                       For 'Broncho-Drug 3.5 mg-capsules for children', the target population part is "children"
                       For 'Adult Chesty Cough Syrup', the target population part is "adult"
http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  PRprofessional

Description:Primarily in the British Imperial culture people tend to have an abbreviation of their professional organization as part of their credential titles.

http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  PharmaceuticalEntityNamePartQualifiersPharmaceuticalEntityNamePartQualifiers

Description: Medication Name Parts are a means of specifying a range of acceptable "official" forms of the name of a product. They are used as patterns against which input name strings may be matched for automatic identification of products from input text reports. While they cover the concepts held under "doseForm" or "route" or "strength" the name parts are not the same and do not fit into a controlled vocabulary in the same way. By specifying up to 8 name parts a much larger range of possible names can be generated.

http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  SCIscientific name

Description: This refers to the product common or scientific name without the trademark or the name of the marketing authorization holder or any other descriptor reflected in the product name.

                    EXAMPLES: 

                    
                       
                          For Agenerase: N/A

                       
                       
                          For Optaflu: Influenza vaccine (surface antigen, inactivated, prepared in cell culture) (2007/2008 season)

                       
                       
                          For Ludiomil: N/A
http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  SFXsuffix

Description:A suffix has a strong association to the immediately preceding name part. A suffix has no implicit leading white space (it has implicit trailing white space though).

http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  SPspouse

Description:The name assumed from the partner in a marital relationship. Usually the spouse's family name. Note that no inference about gender can be made from the existence of spouse names.

http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  STRstrength name

Description: This refers to the strength if present in the medicinal product name. The use of decimal points should be accommodated if required.

                    EXAMPLES:

                    
                       
                          For Agenerase 50 mg soft capsules: 50mg

                       
                       
                          For Ludiomil 25mg-Filmtabletten: 25 mg

                       
                       
                          For Optaflu suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell culture) (2007/2008 season): N/A
http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  TIMETimeOrPeriodName

Description: This refers to a time or time period that may be specified in the text of the medicinal product name

                       Example:
                    

                    
                       For an influenza vaccine 'Drug-FLU season 2008/2009', the time/period part is "2008/2009 season"
http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  TMKtrademark name

Description: This refers to trademark/company element if present in the medicinal product name.

                    EXAMPLES: 

                    
                       
                          for Insulin Human Winthrop Comb 15: Winthrop
http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  TitleStylesTitleStyles

Description:Extra information about the style of a title

http://hl7.org/fhir/v3/EntityNamePartQualifierR22016-11-11  USEintended use name

Description: This refers to the intended use if present in the medicinal product name without the trademark or the name of the marketing authorization holder or any other descriptor reflected in the product name.

                       Examples:
                    

                    
                       For 'Drug-BI Caplets - Heartburn Relief', the intended use part is: "Heartburn Relief"
                       For 'Medicine Honey Syrup for Soothing Coughs' the intended use part is "Soothing Coughs"

Source1

{
  "resourceType": "ValueSet",
  "id": "R3-v3-EntityNamePartQualifierR2-for-R4B",
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
      "valueInteger": 0
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
      "valueCode": "fhir"
    },
    {
      "extension": [
        {
          "url": "packageId",
          "valueId": "hl7.fhir.uv.xver-r3.r4b"
        },
        {
          "url": "version",
          "valueString": "0.1.0"
        },
        {
          "url": "uri",
          "valueUri": "http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r3.r4b"
        }
      ],
      "url": "http://hl7.org/fhir/StructureDefinition/package-source"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
      "valueCode": "trial-use",
      "_valueCode": {
        "extension": [
          {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
            "valueCanonical": "http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r3.r4b"
          }
        ]
      }
    }
  ],
  "url": "http://hl7.org/fhir/uv/xver/ValueSet/R3-v3-EntityNamePartQualifierR2-for-R4B",
  "version": "0.1.0",
  "name": "R3V3EntityNamePartQualifierR2ForR4B",
  "title": "Cross-version ValueSet STU3.v3 Code System EntityNamePartQualifierR2 for use in FHIR R4B",
  "status": "active",
  "experimental": false,
  "date": "2026-03-17T21:02:03.8104715+00:00",
  "publisher": "FHIR Infrastructure",
  "contact": [
    {
      "name": "FHIR Infrastructure",
      "telecom": [
        {
          "system": "url",
          "value": "http://www.hl7.org/Special/committees/fiwg"
        }
      ]
    }
  ],
  "description": "This cross-version ValueSet represents content from `http://hl7.org/fhir/ValueSet/v3-EntityNamePartQualifierR2|2016-11-11` for use in FHIR R4B.",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
          "code": "001",
          "display": "World"
        }
      ]
    }
  ],
  "purpose": "This value set is part of the cross-version definitions generated to enable use of the\r\nvalue set `http://hl7.org/fhir/ValueSet/v3-EntityNamePartQualifierR2|2016-11-11` as defined in FHIR STU3\r\nin FHIR R4B.\r\n\r\nThe source value set is bound to the following FHIR STU3 elements:\r\n* \r\n\r\nAcross FHIR versions, the value set has been mapped as:\r\n* `http://hl7.org/fhir/ValueSet/v3-EntityNamePartQualifierR2|2016-11-11`\n* `http://terminology.hl7.org/ValueSet/v3-EntityNamePartQualifierR2|2018-08-12`\r\n\r\nNote that all concepts are included in this cross-version definition because no concepts have compatible representations\r\n\r\nFollowing are the generation technical comments:\r\nAll concepts in the comparison are listed as identical.\nThe source and target value sets have the same number of active concepts (25).\nFHIR ValueSet `http://hl7.org/fhir/ValueSet/v3-EntityNamePartQualifierR2|2016-11-11`, defined in FHIR STU3 does not have any mapping to FHIR R4B",
  "compose": {
    "include": [
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "concept": [
          {
            "code": "AC",
            "display": "academic"
          },
          {
            "code": "AD",
            "display": "acquired"
          },
          {
            "code": "BR",
            "display": "birth"
          },
          {
            "code": "CL",
            "display": "callme"
          },
          {
            "code": "CON",
            "display": "container name"
          },
          {
            "code": "DEV",
            "display": "device name"
          },
          {
            "code": "FLAV",
            "display": "FlavorName"
          },
          {
            "code": "FORMUL",
            "display": "FormulationPartName"
          },
          {
            "code": "FRM",
            "display": "form name"
          },
          {
            "code": "HON",
            "display": "honorific"
          },
          {
            "code": "IN",
            "display": "initial"
          },
          {
            "code": "INV",
            "display": "invented name"
          },
          {
            "code": "LS",
            "display": "legal status"
          },
          {
            "code": "MID",
            "display": "middle name"
          },
          {
            "code": "NB",
            "display": "nobility"
          },
          {
            "code": "PFX",
            "display": "prefix"
          },
          {
            "code": "POPUL",
            "display": "TargetPopulationName"
          },
          {
            "code": "PR",
            "display": "professional"
          },
          {
            "code": "PharmaceuticalEntityNamePartQualifiers",
            "display": "PharmaceuticalEntityNamePartQualifiers"
          },
          {
            "code": "SCI",
            "display": "scientific name"
          },
          {
            "code": "SFX",
            "display": "suffix"
          },
          {
            "code": "SP",
            "display": "spouse"
          },
          {
            "code": "STR",
            "display": "strength name"
          },
          {
            "code": "TIME",
            "display": "TimeOrPeriodName"
          },
          {
            "code": "TMK",
            "display": "trademark name"
          },
          {
            "code": "TitleStyles",
            "display": "TitleStyles"
          },
          {
            "code": "USE",
            "display": "intended use name"
          }
        ]
      }
    ]
  },
  "expansion": {
    "timestamp": "2026-03-17T21:02:03.8104715+00:00",
    "contains": [
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "AC",
        "display": "academic"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "AD",
        "display": "acquired"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "BR",
        "display": "birth"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "CL",
        "display": "callme"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "CON",
        "display": "container name"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "DEV",
        "display": "device name"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "FLAV",
        "display": "FlavorName"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "FORMUL",
        "display": "FormulationPartName"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "FRM",
        "display": "form name"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "HON",
        "display": "honorific"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "IN",
        "display": "initial"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "INV",
        "display": "invented name"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "LS",
        "display": "legal status"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "MID",
        "display": "middle name"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "NB",
        "display": "nobility"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "PFX",
        "display": "prefix"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "POPUL",
        "display": "TargetPopulationName"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "PR",
        "display": "professional"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "PharmaceuticalEntityNamePartQualifiers",
        "display": "PharmaceuticalEntityNamePartQualifiers"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "SCI",
        "display": "scientific name"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "SFX",
        "display": "suffix"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "SP",
        "display": "spouse"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "STR",
        "display": "strength name"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "TIME",
        "display": "TimeOrPeriodName"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "TMK",
        "display": "trademark name"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "TitleStyles",
        "display": "TitleStyles"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "USE",
        "display": "intended use name"
      }
    ]
  }
}